109 related articles for article (PubMed ID: 1399485)
21. beta-adrenergic receptor genotype and response to salmeterol.
Wechsler ME; Israel E
J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
[No Abstract] [Full Text] [Related]
22. Bronchodilator therapy in asthma.
Boyd G
Acta Microbiol Immunol Hung; 1998; 45(1):143-5. PubMed ID: 9595165
[No Abstract] [Full Text] [Related]
23. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
Cash R; Blonski J
J Fam Pract; 2001 Sep; 50(9):802. PubMed ID: 11674917
[No Abstract] [Full Text] [Related]
24. Salmeterol: a long acting bronchodilator.
Bhadoria DP; Bhadoria P
J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
[No Abstract] [Full Text] [Related]
25. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
26. Onset of action of formoterol versus salmeterol.
Aalbers R; van der Woude HJ
Respir Med; 2007 Apr; 101(4):871-2; author reply 873-4. PubMed ID: 17298879
[No Abstract] [Full Text] [Related]
27. Salmeterol and conventional asthma therapy.
Lipworth BJ
Chest; 2001 Mar; 119(3):986-7. PubMed ID: 11243995
[No Abstract] [Full Text] [Related]
28. [Pharmacy clinics. Drug of the month. Salmeterol (Serevent)].
Scheen AJ
Rev Med Liege; 1995 Jun; 50(6):270-1. PubMed ID: 7618007
[No Abstract] [Full Text] [Related]
29. Salmeterol: its place in asthma management.
Kamada AK; Spahn JD; Blake KV
Ann Pharmacother; 1994 Sep; 28(9):1100-2. PubMed ID: 7803888
[No Abstract] [Full Text] [Related]
30. Asthma group issues guidelines for safe use of salmeterol.
Am J Health Syst Pharm; 1996 Dec; 53(24):2943-4. PubMed ID: 8974156
[No Abstract] [Full Text] [Related]
31. Bronchodilator treatment in asthma.
Sears MR; Taylor DR
BMJ; 1993 Aug; 307(6901):446. PubMed ID: 8374471
[No Abstract] [Full Text] [Related]
32. Bronchodilator treatment in asthma.
Fuller RW; Castle WM; Palmer JB; Hall JR
BMJ; 1993 Sep; 307(6905):683. PubMed ID: 8292148
[No Abstract] [Full Text] [Related]
33. Practical pharmacotherapy for pediatric asthma.
Sherman J; Hendeles L
Pediatr Ann; 2000 Dec; 29(12):768-73. PubMed ID: 11131944
[No Abstract] [Full Text] [Related]
34. Response to treatment in individuals with late-onset asthma.
Matsunaga K; Akamatsu K; Hirano T; Ichinose M
J Am Geriatr Soc; 2012 Aug; 60(8):1587-8. PubMed ID: 22889028
[No Abstract] [Full Text] [Related]
35. SMART therapy.
Bell A; McIvor RA
CMAJ; 2006 Aug; 175(3):276-7. PubMed ID: 16880449
[No Abstract] [Full Text] [Related]
36. Results of prescription event monitoring study of salmeterol.
Mann RD
BMJ; 1994 Oct; 309(6960):1018. PubMed ID: 7950701
[No Abstract] [Full Text] [Related]
37. Doping taboos.
Wolstenholme RJ
Br J Sports Med; 1995 Dec; 29(4):279. PubMed ID: 8808548
[No Abstract] [Full Text] [Related]
38. EG-1 positive eosinophils in asthma.
Stone BD; Elias-Todd T; Parrino J
Am J Respir Crit Care Med; 2001 Jul; 164(1):171-2. PubMed ID: 11435257
[No Abstract] [Full Text] [Related]
39. Another word of caution regarding a new long-acting bronchodilator.
Bone RC
JAMA; 1995 Mar 22-29; 273(12):967-8. PubMed ID: 7884959
[No Abstract] [Full Text] [Related]
40. Effect of salmeterol on airway eosinophils.
Pizzichini MM; Pizzichini E; Hargreave FE
Thorax; 2000 Jan; 55(1):92-3. PubMed ID: 10681264
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
